Ronald A. Greenfield

3.6k total citations
58 papers, 1.8k citations indexed

About

Ronald A. Greenfield is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Ronald A. Greenfield has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 21 papers in Epidemiology and 13 papers in Parasitology. Recurrent topics in Ronald A. Greenfield's work include Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (12 papers) and Parasitic Infections and Diagnostics (9 papers). Ronald A. Greenfield is often cited by papers focused on Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (12 papers) and Parasitic Infections and Diagnostics (9 papers). Ronald A. Greenfield collaborates with scholars based in United States, Canada and Netherlands. Ronald A. Greenfield's co-authors include Michael S. Bronze, Douglas A. Drevets, Leonard N. Slater, Mark M. Huycke, Pieter J. M. Leenen, Gene W. Voskuhl, Jeffrey M. Jones, Linda J. Machado, Wendy Joyce and James B. Hutchins and has published in prestigious journals such as Circulation Research, Cancer and Clinical Microbiology Reviews.

In The Last Decade

Ronald A. Greenfield

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald A. Greenfield United States 24 781 535 243 204 199 58 1.8k
A Ayyagarí India 26 605 0.8× 668 1.2× 425 1.7× 161 0.8× 151 0.8× 135 2.2k
Nevio Cimolai Canada 24 684 0.9× 475 0.9× 202 0.8× 53 0.3× 272 1.4× 118 1.8k
Richard C. Tilton United States 28 613 0.8× 548 1.0× 309 1.3× 358 1.8× 239 1.2× 100 2.0k
J. Carl Craft United States 25 567 0.7× 755 1.4× 224 0.9× 193 0.9× 282 1.4× 46 1.7k
Luciano Zubaran Goldani Brazil 27 1.3k 1.6× 1.4k 2.7× 465 1.9× 171 0.8× 159 0.8× 125 3.2k
F. Jacobs Belgium 26 1.1k 1.4× 1.2k 2.3× 426 1.8× 83 0.4× 110 0.6× 62 2.5k
Gülşen Hasçelik Türkiye 27 608 0.8× 758 1.4× 413 1.7× 77 0.4× 230 1.2× 165 2.6k
Robert Krause Austria 24 625 0.8× 575 1.1× 382 1.6× 103 0.5× 120 0.6× 105 2.3k
Wolfgang Graninger Austria 30 802 1.0× 826 1.5× 405 1.7× 127 0.6× 494 2.5× 105 2.8k
R. Freeman United Kingdom 21 416 0.5× 575 1.1× 328 1.3× 59 0.3× 102 0.5× 113 1.5k

Countries citing papers authored by Ronald A. Greenfield

Since Specialization
Citations

This map shows the geographic impact of Ronald A. Greenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Greenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Greenfield more than expected).

Fields of papers citing papers by Ronald A. Greenfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Greenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Greenfield. The network helps show where Ronald A. Greenfield may publish in the future.

Co-authorship network of co-authors of Ronald A. Greenfield

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Greenfield. A scholar is included among the top collaborators of Ronald A. Greenfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Greenfield. Ronald A. Greenfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bose, Prithviraj, Hiral D. Parekh, Jennifer Holter‐Chakrabarty, & Ronald A. Greenfield. (2011). Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole Prophylaxis. Journal of Clinical Microbiology. 49(4). 1674–1675. 16 indexed citations
2.
Liedtke, Michelle D., et al.. (2011). Congestive Heart Failure Exacerbation Secondary to Itraconazole Therapy. Infectious Diseases in Clinical Practice. 19(6). e19–e20. 2 indexed citations
3.
Liedtke, Michelle D., et al.. (2010). Successful 4-Drug Treatment for Refractory Giardia lamblia. Infectious Diseases in Clinical Practice. 18(4). 275–276. 2 indexed citations
4.
Blevins, Steve M., Ronald A. Greenfield, & Michael S. Bronze. (2008). Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleveland Clinic Journal of Medicine. 75(7). 521–530. 18 indexed citations
5.
Ali, Tauseef, et al.. (2007). Gatifloxacin-associated hypoglycemia.. PubMed. 100(11). 425–8. 1 indexed citations
6.
Greenfield, Ronald A., et al.. (2005). Biodefense : principles and pathogens. 11 indexed citations
7.
Postier, Russell G., et al.. (2005). Infectious Aortitis. Current Treatment Options in Cardiovascular Medicine. 7(2). 89–97. 85 indexed citations
8.
Jackson, Lydgia, Douglas A. Drevets, Zhaoming Dong, Ronald A. Greenfield, & J W Murphy. (2005). Levels of L‐Selectin (CD62L) on Human Leukocytes in Disseminated Cryptococcosis With and Without Associated HIV‐1 Infection. The Journal of Infectious Diseases. 191(8). 1361–1367. 8 indexed citations
9.
Sawalha, Amr H., et al.. (2003). Panniculitis. JCR Journal of Clinical Rheumatology. 9(4). 259–262. 12 indexed citations
10.
Bronze, Michael S. & Ronald A. Greenfield. (2003). Preventive and therapeutic approaches to viral agents of bioterrorism. Drug Discovery Today. 8(16). 740–745. 9 indexed citations
11.
Bronze, Michael S., Mark M. Huycke, Linda J. Machado, Gene W. Voskuhl, & Ronald A. Greenfield. (2002). Viral Agents as Biological Weapons and Agents of Bioterrorism. The American Journal of the Medical Sciences. 323(6). 316–325. 73 indexed citations
12.
Greenfield, Ronald A., et al.. (2002). Bacterial Pathogens as Biological Weapons and Agents of Bioterrorism. The American Journal of the Medical Sciences. 323(6). 299–315. 96 indexed citations
13.
Brewer, Thomas G., et al.. (1999). Absolute Bioavailability of Halofantrine-Hcl: Effect of Ranitidine and Pentagastrin Treatment. Clinical Research and Regulatory Affairs. 16(1-2). 13–28. 2 indexed citations
15.
Kuhls, T L, et al.. (1995). Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiency. Infection and Immunity. 63(9). 3582–3586. 5 indexed citations
16.
Steele, Marilyn I., T L Kuhls, C.S. Reddy Meka, et al.. (1995). A Cryptosporidium parvum genomic region encoding hemolytic activity. Infection and Immunity. 63(10). 3840–3845. 20 indexed citations
17.
Naguib, Tarek, Mark M. Huycke, James A. Pederson, et al.. (1995). Apophysomyces elegans infection in a renal transplant recipient. American Journal of Kidney Diseases. 26(2). 381–384. 35 indexed citations
18.
Kuhls, T L, et al.. (1993). Cryptosporidium parvum Infection after Abrogation of Natural Killer Cell Activity in Normal and Severe Combined Immunodeficiency Mice. Journal of Parasitology. 79(2). 295–295. 30 indexed citations
19.
Joyce, Wendy, et al.. (1991). Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infection and Immunity. 59(6). 2116–2119. 46 indexed citations
20.
Greenfield, Ronald A., et al.. (1983). Serial Enzyme-Linked Immunosorbent Assays for Antibody to Candida Antigens During Induction Chemotherapy for Acute Leukemia. The Journal of Infectious Diseases. 148(2). 275–283. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026